Cardiomyocyte-specific knockout of ADAM17 alleviates doxorubicin-induced cardiomyopathy via inhibiting TNFα-TRAF3-TAK1-MAPK axis
Signal Transduct Target Ther. 2024 Oct 16;9(1):273. doi: 10.1038/s41392-024-01977-z. ABSTRACT The pathogenesis of doxorubicin-induced cardiomyopathy remains unclear. This study was carried out to test our …